细胞凋亡
阿霉素
空泡化
程序性细胞死亡
内源性凋亡
内质网
线粒体
纳米医学
癌症研究
细胞色素c
谷胱甘肽
化学
细胞生物学
药理学
生物
化疗
医学
纳米技术
材料科学
生物化学
半胱氨酸蛋白酶
病理
纳米颗粒
内科学
酶
作者
Rongrong Zheng,Linping Zhao,Xiayun Chen,Lingshan Liu,Yibin Liu,Xiantong Chen,Chang Wang,Xiyong Yu,Hong Cheng,Shiying Li
标识
DOI:10.1016/j.jconrel.2021.06.021
摘要
Apoptosis resistance of tumor cells often results in chemoresistance and treatment failure in clinic. In this work, a Cu2+-coordinated morusin/doxorubicin biological organizer (designated as COMBO) is designed to combat cellular resistance to apoptosis for combined tumor therapy. By virtue of the coordination and π-π stacking effects, the self-assembled COMBO possesses nanometer particle size, narrow and homogenous graininess distribution as well as a good dispersion stability. Moreover, COMBO could be disassembled by glutathione (GSH) with an effective drug release and fluorescence recovery. Morusin-mediated paraptosis could induce extensive vacuolization through the dilation of endoplasmic reticulum (ER) and mitochondria, leading to non-apoptotic programmed cell death (PCD) regardless of the cellular resistance to apoptosis. Furthermore, the released doxorubicin prefers to locate in cell nucleus to cause cell apoptosis for combined chemotherapy. By the joint action of paraptosis and apoptosis, COMBO exhibits a great superiority over monotherapy in tumor inhibition with a low system toxicity. This study may open a window in the development of self-delivery nanomedicine for overcoming apoptosis resistance in tumor therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI